S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 237-245

  Devine, Kathleen M ^a   Smicun, Yoel ^a   Hope, Joanie Mayer ^a   Fishman, David A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Invasion; LPA; MMP 2; MT1 MMP; N cadherin; Ovarian cancer; S1P; uPA

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GELATINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; MATRIGEL; MATRIX METALLOPROTEINASE 14; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; PERTUSSIS TOXIN; RAC PROTEIN; SPHINGOSINE 1 PHOSPHATE; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE MICROSCOPY; FLUOROMETRY; GEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PERTUSSIS TOXIN; RAC GTP-BINDING PROTEINS; SPHINGOSINE; URINARY PLASMINOGEN ACTIVATOR;

EID: 47249089511     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.013     Document Type: Article

References (36)

1. Menon U., Skates S.J., Lewis S., Rosenthal A.N., Rufford B., Sibley K., et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 23 31 (2005) 7919-7926
2. Society A. Cancer facts and figures 2003; 2003.
3. Tan D.S., Agarwal R., and Kaye S.B. Mechanisms of transcoelomic metastasis in ovarian cancer. [Review] [85 refs]. Lancet Oncol 7 11 (2006) 925-934
4. Westermann A.M., Havik E., Postma F.R., Beijnen J.H., Dalesio O., Moolenaar W.H., et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 9 4 (1998) 437-442
5. Xu Y., Gaudette D.C., Boynton J.D., Frankel A., Fang X.J., Sharma A., et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1 10 (1995) 1223-1232
6. Hong G., Baudhuin L.M., and Xu Y. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells. FEBS Lett 460 3 (1999) 513-518.
7. Fishman D.A., Liu Y., Ellerbroek S.M., and Stack M.S. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 61 7 (2001) 3194-3199.
8. So J., Navari J., Wang F.Q., and Fishman D.A. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol 95 2 (2004) 314-322
9. Ishii I., Fukushima N., Ye X., and Chun J. Lysophospholipid receptors: signaling and biology. [Review] [210 refs]. Ann Rev Biochem 73 (2004) 321-354
10. Sutphen R., Xu Y., Wilbanks G.D., Fiorica J., Grendys Jr. E.C., LaPolla J.P., et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomark Prev 13 7 (2004) 1185-1191
11. Xu Y., Shen Z., Wiper D.W., Wu M., Morton R.E., Elson P., et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.[see comment]. JAMA 280 8 (1998) 719-723
12. Smicun Y., Reierstad S., Wang F.Q., Lee C., and Fishman D.A. S1P regulation of ovarian carcinoma invasiveness. Gynecol Oncol 103 (2006) 952-959
13. Radeff-Huang J., Seasholtz T.M., Matteo R.G., and Brown J.H. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. [Review] [124 refs]. J Cell Biochem 92 5 (2004) 949-966
14. Taha T.A., Argraves K.M., and Obeid L.M. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. [Review] [59 refs]. Biochim Biophys Acta (2004) 1
15. Moolenaar W.H., van Meeteren L.A., and Giepmans B.N. The ins and outs of lysophosphatidic acid signaling. [Review] [92 refs]. BioEssays 26 8 (2004) 870-881
16. Hall A. Rho GTPases and the actin cytoskeleton. [Review] [50 refs]. Science 279 5350 (1998) 509-514
17. Do T.V., Symowicz J.C., Berman D.M., Liotta L.A., Petricoin III E.F., Stack M.S., et al. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Mol Cancer Res: MCR 5 2 (2007) 121-131
18. Vihinen P., and Kahari V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. [Review] [165 refs]. Int J Cancer 99 2 (2002) 157-166
19. Yoon S.O., Park S.J., Yun C.H., and Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. [Review] [85 refs]. J Biochem Mol Biol 36 1 (2003) 128-137
20. Wang F.Q., So J., Reierstad S., and Fishman D.A. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114 1 (2005) 19-31
21. Pustilnik T.B., Estrella V., Wiener J.R., Mao M., Eder A., Watt M.A., et al. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res 5 11 (1999) 3704-3710
22. Keely P., Parise L., and Juliano R. Integrins and GTPases in tumour cell growth, motility and invasion. [Review] [70 refs]. Trends Cell Biol 8 3 (1998) 101-106.
23. Zhuge Y., and Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation. Role in cell invasion across collagen barrier. J Biol Chem 276 19 (2001) 16248-16256
24. Osenkowski P., Toth M., and Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). [Review] [77 refs]. J Cell Physiol 200 1 (2004) 2-10.
25. Derycke L.D., and Bracke M.E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. [Review] [140 refs]. Int J Dev Biol 48 5-6 (2004) 463-476
26. Smicun Y., Gil O., Devine K., and Fishman D.A. S1P and LPA have an attachment dependent regulatory effect on invasion of epithelial ovarian cancer cells. Gynecol Oncol 107 (2007) 298-309
27. Moser T.L., Young T.N., Rodriguez G.C., Pizzo S.V., Bast Jr. R.C., and Stack M.S. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer 56 4 (1994) 552-559
28. Moser T.L., Enghild J.J., Pizzo S.V., and Stack M.S. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem J 307 Pt 3 (1995) 867-873
29. Lepley D., Paik J.H., Hla T., and Ferrer F. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 65 9 (2005) 3788-3795
30. Takuwa Y., Takuwa N., and Sugimoto N. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. [Review] [39 refs]. J Biochem 131 6 (2002) 767-771
31. Yamaguchi H., Kitayama J., Takuwa N., Arikawa K., Inoki I., Takehara K., et al. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J 374 Pt 3 (2003) 715-722
32. Jordan J.D., He J.C., Eungdamrong N.J., Gomes I., Ali W., Nguyen T., et al. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. J Biol Chem 280 12 (2005) 11413-11421
33. Jaffer Z.M., and Chernoff J. The cross-Rho'ds of cell-cell adhesion. [Review] [50 refs]. J Biol Chem 279 34 (2004) 35123-35126
34. Sundfeldt K. Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. [Review] [88 refs]. Mol Cell Endocrinol 202 1-2 (2003) 89-96
35. Darai E., Scoazec J.Y., Walker-Combrouze F., Mlika-Cabanne N., Feldmann G., Madelenat P., et al. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Human Pathol 28 8 (1997) 922-928
36. Zeineldin R., Rosenberg M., Ortega D., Buhr C., Chavez M.G., Stack M.S., et al. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Mol Carcinog 45 11 (2006) 851-860